Preventive care use among COVID-19 without major rebound has declined significantly

According to a new analysis, despite the resumption of medical offices, the use of preventive care in the coronovirus epidemic has declined significantly and has not resumed.

According to the not-for-profit Health Care Cost Institute (HCCI), childhood vaccines fell by 60 percent at the height of the epidemic in April 2019 and were close to 30 percent as of June.

Mammograms and pap smears were down nearly 80 percent in April and were down nearly a quarter from 2019 until June.

The data comes from a sample of millions of health claims in 18 different states and displays the most preventive services, especially in mid-March through 2020, compared to 2019.

Even as of June, usage was running below 2019 levels.

Colonoscopy had the biggest drop in mid-April, compared to 2019, at a point in mid-April of about 90 percent. As of June, processes have accelerated, but are down about 30 percent from last year.

The epidemic, which fell 77 percent at the height of the epidemic, is still 23 percent lower.

The decision to avoid preventive care can have serious implications for Americans’ long-term health and well-being, especially for children.

Childhood immunity declined by nearly 60 percent in mid-April of 2020 compared to 2019. It was 75 percent for meningitis and up to 33 percent of HPV vaccines for others, such as diphtheria, tetanus, and acellular enteritis vaccine family.

Parents are concerned about possibly exposing their children to coronaviruses. Although other diseases may pose a greater risk to children than COVID-19, messages about staying home and going to the doctor only in emergencies contributed to the decline.

Vaccine rates had previously declined in some parts of the country, and the US had lost the status of measles eradication last year.